Citation 167065

GONZALEZ,AG: DARIAS,V: SUAREZ,MC: JANSSEN,K:. (1983). PRELIMINARY PHARMACOBIOLOGICAL STUDY OF NEW STEROIDAL SAPOGENINS.. 38(1)

Citation Details

Title	PRELIMINARY PHARMACOBIOLOGICAL STUDY OF NEW STEROIDAL SAPOGENINS.
Authors	GONZALEZ,AG: DARIAS,V: SUAREZ,MC: JANSSEN,K:
Year	1983
Volume	38
Issue	1

Summary

Year: 1983

Journal: Unknown

Organisms and Their Experiments (4)

Dracaena draco (AGAVACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DRACOGENIN	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DRACOGENIN	INACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	DRACOGENIN	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	DRACOGENIN	INACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	DRACOGENIN	INACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	DRACOGENIN	INACTIVE
7	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	DRACOGENIN	ACTIVE
8	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	DRACOGENIN	INACTIVE

Isoplexis canariensis (SCROPHULARIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CRESTAGENIN	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CRESTAGENIN	INACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRESTAGENIN	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRESTAGENIN	INACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRESTAGENIN	INACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRESTAGENIN	INACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRESTAGENIN	INACTIVE
8	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRESTAGENIN	ACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OF	ANTHRAQUINONE,1-HYDROXY-4-METHOXY-2-METHYL:ANTHRAQUINONE,1-HYDROXY-3-METHYL:ANTHRAQUINONE,1-4-DIHYDROXY-2-METHYL:	None
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTHRAQUINONE,1-HYDROXY-4-METHOXY-2-METHYL:ANTHRAQUINONE,1-HYDROXY-3-METHYL:ANTHRAQUINONE,1-4-DIHYDROXY-2-METHYL:	INACTIVE

Semele androgyna (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ISOPLEXIGENIN B	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ISOPLEXIGENIN B	INACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ISOPLEXIGENIN B	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ISOPLEXIGENIN B	INACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ISOPLEXIGENIN B	INACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ISOPLEXIGENIN B	INACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ISOPLEXIGENIN B	INACTIVE
8	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ISOPLEXIGENIN B	ACTIVE

Solanum vespertilio (SOLANACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VESPERTILIN	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	VESPERTILIN	ACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VESPERTILIN	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VESPERTILIN	ACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VESPERTILIN	ACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VESPERTILIN	INACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VESPERTILIN	INACTIVE
8	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VESPERTILIN	ACTIVE
9	TOXIC EFFECT(GENERAL)	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO	VESPERTILIN	ACTIVE
10	CNS DEPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	VESPERTILIN	ACTIVE
11	TOXIC EFFECT(GENERAL)	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO	VESPERTILIN	ACTIVE
12	CARDIOVASCULAR EFFECTS(UNSPECIFIED)	PHARMACOLOGY OF COMPOUND - IN VIVO	VESPERTILIN	INACTIVE
13	ANTIHISTAMINE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VESPERTILIN	ACTIVE

Show SPARQL Queries (1)